|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A phase I evaluation of multitargeted antifolate ( MTA, LY231514 ), administered every 21 days, utilizing the modified continual reassessment method for dose es- calation显示文摘 | Rinaldi DA Kuhn JG Bun'is HA | 1999 | Cancer Chemother Pharmacol1999，44，5： | 1 |
| 2 | Word-stem completion priming for perceptually and conceptually encoded words in patients with Alzheimer's disease显示文摘 | Fleischman DA Gabrieli JDE Rinaldi JA | 1996 | Neuropsychologia1996，35，： | 1 |
| 3 | A phase I evaluation of multitargeted antifolate (MTA,LY231514),administered every 21 days,utilizing the modified continual reassessment method for dose escalation 显示文摘 | KUHN JG BURRIS HA | 1999 | Cancer Chemother Pharmacol1999，44，5： | 1 |
| 4 | Initial phase I evaluation of the novel thymidylate synthase inhibitor, LY231514,using the modified continual reassessment metheod for dose escalation显示文摘 | RINALDI DA BURRI HA DORR FA | 1995 | J Clin Oncol1995，13，11： | 1 |
| 5 | A phase I evaluation of muhitargeted antifolate (MTA, IN231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation 显示文摘 | RINALDI DA KUHN JG BURRI HA | 1999 | Cancer Chemother Pharmacol1999，44，5： | 1 |
| 6 | Word-stem comple- tion priming for perceptually and conceptually encoded words in pa- tients with Alzheimer' s disease 显示文摘 | Fleischman DA Gabrieli JD Rinaldi JA | 1997 | Neuropsychologia1997，35，1： | 1 |
| 7 | A Phase Ⅱ trial of topotecan and gemcitabine in patients with previously treated, advanced nonsmall cell lung carcinoma显示文摘 | Rinaldi DA Lormand NA Brien'e JE | 2002 | Cancer2002，95，6： | 1 |
| 8 | Initial phase I evaluation of the novel thymidylate synthase inhibitor, LY231514, using the modified continual reassessment method for dose escalation显示文摘 | BURRIS HA DORR EA | 1995 | J Clin Oncol1995，13，11： | 1 |
| 9 | A phase Ⅰ evaluation of muhitargeted antifolate ( MTA, LY231514 ), administered every 21 days, utilizing the modified continual reassessment method for dose escalation显示文摘 | Rinaldi DA Kuhn JG Burris HA | 1999 | Cancer Chemother Pharmacol1999，44，5： | 1 |
| 10 | lnternet- accessible DNA sequence database for identifying Fusaria from human and animal infections显示文摘 | O'Donnell K Sutton DA Rinaldi MG | | J Clin Microbiol0，48，10： | 1 |
| 11 | A phase I evaluation of multitargeted antifolate (MTA, LY231514), administered every 21 days,utilizing the modified continual reassessment method for dose escalation 显示文摘 | Rinaldi DA Kuhn JG Burris HA | 1999 | Cancer Chemacol Pharmacol1999，44，： | 1 |
| 12 | Word-stem completion priming for perceptually and conceptually encoded words in patients with Alzheimer's disease显示文摘 | Fleischman DA Gabrieli JDE Rinaldi JA | 1996 | Neuropsychologia1996，35，： | 1 |
| 13 | A phase I evaluation of multitargeted antifolate (MTA, LY231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation显示文摘 | Rinaldi DA Kuhn JG Burris HA | 1999 | Cancer Chemother Pharmacol1999，44，5： | 1 |
| 14 | Randomized placebo-controlled trials of the matrix metanoproteinase inhibitor(MMPI) BAY 12 -9566 as adjuvant therapy for patients with small cell and non - small cell lung cancer显示文摘 | Rigas JR Denham CA Rinaldi DA | 2003 | Proc Am Soc Clin oncol2003，22，： | 1 |
| 15 | Initial Phase I evaluation of the novel thymidylate synthase inhibitor, LY231514, using the modified continual reassessment method for dose escalation 显示文摘 | Rinaldi DA Burris HA Dorr FA | 1995 | J Clin Oncol1995，13，： | 1 |
| 16 | A phase I evaluation of multitargeted antifolate (MTA, LY231514), administtered every 21 days, utilizing the modified continual reassessment method for dose escalation 显示文摘 | Rinaldi DA Kuhn JG Burris HA | 1999 | Cancer Chemother Pharmacol1999，44，5： | 1 |
| 17 | Primary central nervous system phaeohyphomycosis:A review of 101 cases显示文摘 | Revankar SG Sutton DA Rinaldi MG | 2004 | Clin Infect Dis2004，38，2： | 1 |
| 18 | Intemet-acces-sible DNA sequence database for identifying Fusaria from hu-man and animal infections 显示文摘 | O'Donnell K Sutton DA Rinaldi MG | 2010 | Journal of Clinical Microbiol-ogy2010，48，10： | 1 |
| 19 | Unprecedented Low-Cost Hybrid Material for CO2 and CH4 Separation显示文摘 | Murilo Pereira Moises Joziane Gimenes Meneguin Cleiser Thiago Pereira da Silva Vicente Lira Kupfer Pedro Augusto Arroyo Andrelson Wellington Rinaldi Emerson Marcelo Girotto Silvia Luciana Favaro Eduardo Radovanovic | 2015 | Journal of Chemistry and Chemical Engineering2015，9，5： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员